.Merck beats revenues desires, increases sales overview on sturdy need for best medicines like Keytruda CNBCMerck & Co. (MRK United States) Trumps Revenue Forecasts as Keytruda Purchases Rise BloombergMerck Stock: Pharma Giant Posts Strong End Results, However Outlook Falls Short Real estate investor's Company DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck defeats profit as well as purchases expectations amidst Keytruda strength, however provides blended full-year outlook MarketWatch.